The most recent meta-analysis of MPNST survival outcomes after surgery found the overall survival (OS) to be 47% for MPNSTs and 50% for MPNSTs in the NF1 cohort [16]. This evidence concerns the gene NF1 and malignant peripheral nerve sheath tumor.